IRIS Accounts Production v25.2.0.378 06159360 director 1.4.24 31.3.25 31.3.25 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh061593602024-03-31061593602025-03-31061593602024-04-012025-03-31061593602023-03-31061593602023-04-012024-03-31061593602024-03-3106159360ns15:EnglandWales2024-04-012025-03-3106159360ns14:PoundSterling2024-04-012025-03-3106159360ns10:Director12024-04-012025-03-3106159360ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3106159360ns10:SmallEntities2024-04-012025-03-3106159360ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3106159360ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3106159360ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3106159360ns10:FullAccounts2024-04-012025-03-3106159360ns10:CompanySecretary12024-04-012025-03-3106159360ns10:RegisteredOffice2024-04-012025-03-3106159360ns5:CurrentFinancialInstruments2025-03-3106159360ns5:CurrentFinancialInstruments2024-03-3106159360ns5:ShareCapital2025-03-3106159360ns5:ShareCapital2024-03-3106159360ns5:RetainedEarningsAccumulatedLosses2025-03-3106159360ns5:RetainedEarningsAccumulatedLosses2024-03-31
REGISTERED NUMBER: 06159360 (England and Wales)















Unaudited Financial Statements

For The Year Ended 31 March 2025

for

DM PHARMA SOLUTIONS LIMITED

DM PHARMA SOLUTIONS LIMITED (REGISTERED NUMBER: 06159360)

Contents of the Financial Statements
For The Year Ended 31 March 2025










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


DM PHARMA SOLUTIONS LIMITED

Company Information
For The Year Ended 31 March 2025







DIRECTOR: Ms S T Thorn





SECRETARY:





REGISTERED OFFICE: 7 Eton Close
Datchet
Slough
Berkshire
SL3 9BE





REGISTERED NUMBER: 06159360 (England and Wales)





ACCOUNTANTS: Godfrey, Anderson & Co
6 Portland Business Centre
Manor House Lane
Datchet
Berkshire
SL3 9EG

DM PHARMA SOLUTIONS LIMITED (REGISTERED NUMBER: 06159360)

Balance Sheet
31 March 2025

31.3.25 31.3.24
Notes £    £   
CURRENT ASSETS
Cash at bank 109,475 107,116

CREDITORS
Amounts falling due within one year 4 1,427 985
NET CURRENT ASSETS 108,048 106,131
TOTAL ASSETS LESS CURRENT
LIABILITIES

108,048

106,131

CAPITAL AND RESERVES
Called up share capital 10 10
Retained earnings 108,038 106,121
108,048 106,131

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 15 August 2025 and were signed by:



Ms S T Thorn - Director


DM PHARMA SOLUTIONS LIMITED (REGISTERED NUMBER: 06159360)

Notes to the Financial Statements
For The Year Ended 31 March 2025


1. STATUTORY INFORMATION

DM Pharma Solutions Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2024 - 1 ) .

4. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Taxation and social security 451 191
Other creditors 976 794
1,427 985

DM PHARMA SOLUTIONS LIMITED (REGISTERED NUMBER: 06159360)

Notes to the Financial Statements - continued
For The Year Ended 31 March 2025


5. RELATED PARTY DISCLOSURE

The company trades from premises owned by Sandra Thorn. In the year under review the company was charged £169 (2024 £119) for the use of those premises.